Market Closed

CABA
Cabaletta Bio
$ 1.28
-3.76%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated 2 days ago

Cabaletta Bio News

Latest Cabaletta Bio Stock News & CABA Headlines

Cabaletta Bio Reports Third Quarter 2026 Financial Results and Provides Business Update
11 days ago | globenewswire.com
Cabaletta Bio to Participate in Upcoming Investor Conferences
13 days ago | globenewswire.com
Cabaletta Bio: 40% Sell-Off Creates An Opportunity Despite Cash Concerns
a month ago | seekingalpha.com
Cabaletta Bio, Inc. (CABA) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
2 months ago | seekingalpha.com
Cabaletta Bio to Participate in Upcoming Investor Conferences
2 months ago | globenewswire.com
Cabaletta Bio Reports Second Quarter 2026 Financial Results and Provides Business Update
3 months ago | globenewswire.com
Cabaletta Bio: The Market Sold The EULAR News, I'm Buying
5 months ago | seekingalpha.com
Cabaletta Bio, Inc. (CABA) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
5 months ago | seekingalpha.com
Cabaletta Bio Announces New Rese-cel Data and Development Updates Across Autoimmune Portfolio, Including Encouraging Early PC-Free Lupus Findings, at EULAR 2026 Congress
5 months ago | globenewswire.com
Is Cabaletta Bio (CABA) Stock Outpacing Its Medical Peers This Year?
6 months ago | zacks.com
Load More

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

oinCodex Android App
CoinCodex Mobile App
Market Closed

CABA
Cabaletta Bio
$ 1.28
-3.76%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated 2 days ago